PL3452075T3 - Oftalmiczna kompozycja farmaceutyczna - Google Patents

Oftalmiczna kompozycja farmaceutyczna

Info

Publication number
PL3452075T3
PL3452075T3 PL17907584T PL17907584T PL3452075T3 PL 3452075 T3 PL3452075 T3 PL 3452075T3 PL 17907584 T PL17907584 T PL 17907584T PL 17907584 T PL17907584 T PL 17907584T PL 3452075 T3 PL3452075 T3 PL 3452075T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
ophthalmic pharmaceutical
ophthalmic
composition
pharmaceutical
Prior art date
Application number
PL17907584T
Other languages
English (en)
Inventor
Guang-Jin Im
Byung-Jhip Ha
Na-Won PARK
Yong-Seop PARK
Original Assignee
Sam Chun Dang Pharm. Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sam Chun Dang Pharm. Co., Ltd. filed Critical Sam Chun Dang Pharm. Co., Ltd.
Publication of PL3452075T3 publication Critical patent/PL3452075T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL17907584T 2017-04-26 2017-10-13 Oftalmiczna kompozycja farmaceutyczna PL3452075T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20170053782 2017-04-26
KR1020170120262A KR101861163B1 (ko) 2017-04-26 2017-09-19 안과용 약학 조성물
PCT/KR2017/011293 WO2018199408A1 (en) 2017-04-26 2017-10-13 Ophthalmic pharmaceutical composition
EP17907584.1A EP3452075B1 (en) 2017-04-26 2017-10-13 Ophthalmic pharmaceutical composition

Publications (1)

Publication Number Publication Date
PL3452075T3 true PL3452075T3 (pl) 2022-02-21

Family

ID=62299585

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17907584T PL3452075T3 (pl) 2017-04-26 2017-10-13 Oftalmiczna kompozycja farmaceutyczna

Country Status (9)

Country Link
US (1) US10646546B2 (pl)
EP (1) EP3452075B1 (pl)
JP (1) JP6677827B2 (pl)
KR (1) KR101861163B1 (pl)
CN (1) CN109475597B (pl)
ES (1) ES2902325T3 (pl)
PL (1) PL3452075T3 (pl)
TW (1) TWI763802B (pl)
WO (1) WO2018199408A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2944306T1 (sl) 2006-06-16 2021-04-30 Regeneron Pharmaceuticals, Inc. Formulacije antagonista VEGF, primerne za intravitrealno dajanje
CA3043487A1 (en) * 2016-11-21 2018-05-24 Just-Evotec Biologics Inc Aflibercept formulations and uses thereof
MA50908A (fr) * 2017-11-17 2020-09-23 Amgen Inc Formulations de protéines de fusion vegfr-fc
JP7235770B2 (ja) 2018-05-10 2023-03-08 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 高濃度vegf受容体融合タンパク質を含む製剤
EP3851096A4 (en) 2018-09-10 2022-07-06 Samsung Bioepis Co., Ltd. LIQUID COMPOSITION WITH PROTEIN
KR102286892B1 (ko) 2019-07-08 2021-08-06 삼천당제약주식회사 안과용 단백질 제제의 정제방법
KR20240007293A (ko) 2019-12-06 2024-01-16 리제너론 파아마슈티컬스, 인크. 항-vegf 단백질 조성물 및 이를 생산하는 방법
KR20210077645A (ko) * 2019-12-17 2021-06-25 주식회사 프로젠 신규 주사제 제형
JP2023535933A (ja) * 2020-07-24 2023-08-22 パンジェン バイオテック インコーポレイテッド 眼科用液状組成物
KR102720956B1 (ko) 2020-12-15 2024-10-24 삼천당제약주식회사 안과용 제형을 포함하는 시린지
US20240059768A1 (en) * 2021-01-14 2024-02-22 Hanall Biopharma Co., Ltd. A stable ophthalmic composition comprising tanfanercept, which is free of stabilizer or substantially free of stabilizer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2944306T1 (sl) 2006-06-16 2021-04-30 Regeneron Pharmaceuticals, Inc. Formulacije antagonista VEGF, primerne za intravitrealno dajanje
ES2457442T3 (es) 2009-05-08 2014-04-25 Pari Pharma Gmbh Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
US20130323242A1 (en) 2012-06-01 2013-12-05 Ophthotech Corp. Compositions comprising an anti-pdgf aptamer and a vegf antagonist
EA201492289A1 (ru) 2012-06-01 2015-05-29 Офтотек Корпорейшн Композиции, содержащие аптамер против pdgf и антагонист vegf
BR112016006455A2 (pt) 2013-09-27 2017-08-01 Hanmi Pharm Ind Co Ltd ?formulação de conjugado de hormônio de crescimento humano de ação prolongada?
AR102494A1 (es) * 2014-11-07 2017-03-01 Novartis Ag Métodos para tratar enfermedades oculares
KR101808234B1 (ko) * 2015-06-23 2017-12-12 (주)알테오젠 IgG Fc 도메인을 가지는 융합 단백질의 안정한 액상 제제
CN105496955A (zh) * 2015-12-11 2016-04-20 北京蓝丹医药科技有限公司 一种二氟泼尼酯眼用乳剂及其制备方法
CA3043487A1 (en) * 2016-11-21 2018-05-24 Just-Evotec Biologics Inc Aflibercept formulations and uses thereof
EP3684332A1 (en) * 2017-09-18 2020-07-29 Amgen Inc. Vegfr-fc fusion protein formulations

Also Published As

Publication number Publication date
EP3452075A1 (en) 2019-03-13
TW201838646A (zh) 2018-11-01
JP6677827B2 (ja) 2020-04-08
WO2018199408A1 (en) 2018-11-01
CN109475597A (zh) 2019-03-15
TWI763802B (zh) 2022-05-11
ES2902325T3 (es) 2022-03-28
EP3452075A4 (en) 2019-12-11
US20190160145A1 (en) 2019-05-30
EP3452075B1 (en) 2021-11-24
JP2019517513A (ja) 2019-06-24
CN109475597B (zh) 2022-03-22
KR101861163B1 (ko) 2018-05-25
US10646546B2 (en) 2020-05-12

Similar Documents

Publication Publication Date Title
GB2568579B (en) Ophthalmic drug compositions
GB201913962D0 (en) Ophthalmic drug compositions
IL265360B (en) Pharmaceutical composition
IL269061A (en) A pharmaceutical preparation containing Selexifag
IL271986B1 (en) pharmaceutical preparation
IL265349A (en) Pharmaceutical composition
GB201619525D0 (en) Ophthalmic composition
PL3348260T3 (pl) Kompozycja farmaceutyczna tramadolu do zastosowania oftalmicznego
GB201712159D0 (en) Pharmaceutical composition
SMT202400178T1 (it) Composizioni oftalmiche farmaceutiche prive di conservanti
PL3583943T3 (pl) Kompozycja farmaceutyczna
IL263040A (en) Pharmaceutical composition comprising eteplirsen
IL272419A (en) Pharmaceutical composition
GB201719447D0 (en) Pharmaceutical composition
PL3313370T3 (pl) Okulistyczna kompozycja farmaceutyczna
PL3646867T3 (pl) Kompozycja farmaceutyczna
PL3454838T3 (pl) Kompozycja farmaceutyczna
GB201615917D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
IL271513A (en) Innovative pharmaceutical composition
GB201616088D0 (en) Pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
PL3424500T3 (pl) Kompozycja farmaceutyczna zawierająca famitynib
GB201620519D0 (en) Pharmaceutical composition
GB201708329D0 (en) Pharmaceutical composition